Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000234813 is classified as a **pseudogene** that shares partial sequence similarity to the **glycogen synthase kinase 3** enzyme family (GSK-3). Pseudogenes are genomic sequences resembling functional genes but are nonfunctional due to the accumulation of disabling mutations, lack of necessary regulatory elements, or loss of coding potential[2][5]. While some pseudogenes can exert regulatory functions at the RNA level, ENSG00000234813 is not documented to have any functional biological activity or disease association. It does not encode a protein and is not considered a drug target or receptor[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of glycogen synthase kinase 3 (ENSG00000234813 (no widely accepted protein/gene symbol)).